The 1 analysts offering 12-month price forecasts for Minerva Neurosciences Inc have a median target of 11.00, with a high estimate of 11.00 and a low estimate of 11.00. The median estimate represents a +56.03% increase from the last price of 7.05.
The current consensus among 1 polled investment analysts is to Hold stock in Minerva Neurosciences Inc. This rating has held steady since August, when it was downgraded from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.97
Reporting Date Mar 11
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.